NCT01250210View on ClinicalTrials.gov

Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

PHASE2CompletedINTERVENTIONAL

Enrollment

123

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Ovulation Suppression

Interventions

DRUG

levonorgestrel and ethinyl estradiol

pregnancy prevention

Trial Locations (11)

19046

Jenkintown

19114

Philadelphia

27103

Winston-Salem

27518

Cary

30328

Sandy Springs

33026

Pembroke Pines

33607

Tampa

37620

Bristol

80218

Denver

85712

Tucson

92108

San Diego

Sponsors

Lead Sponsor

Agile Therapeutics

All Listed Sponsors

lead

Agile Therapeutics

INDUSTRY